Profound Medical Corp (PRN : TSX)
Common Stock
$9.33
CAD
-0.27 (-2.81%)
Last updated: 2026-06-22
PRN
Profound Medical Corp
WealthAwesomePerformance
1 Day
-2.81%
1 Week
-1.17%
1 Month
-1.89%
YTD
-11.56%
Key Statistics
Market Cap
$348.84M
52W High
$12.40
52W Low
$5.23
P/E Ratio
-
50 Day MA
$9.38
200 Day MA
$8.93
Beta
0.52
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 6/22/2026 | $9.77 | $9.77 | $9.22 | $9.33 | $9.33 | 28,720 |
| 6/19/2026 | $9.33 | $9.71 | $9.33 | $9.60 | $9.60 | 2,123 |
| 6/18/2026 | $9.34 | $9.73 | $9.34 | $9.64 | $9.64 | 5,453 |
| 6/17/2026 | $9.54 | $9.78 | $9.22 | $9.34 | $9.34 | 4,969 |
| 6/16/2026 | $9.54 | $9.65 | $9.26 | $9.55 | $9.55 | 44,296 |
| 6/15/2026 | $9.40 | $9.55 | $9.35 | $9.44 | $9.44 | 21,506 |
| 6/12/2026 | $9.23 | $9.34 | $9.23 | $9.27 | $9.27 | 911 |
| 6/11/2026 | $9.44 | $9.51 | $9.15 | $9.32 | $9.32 | 2,857 |
| 6/10/2026 | $9.40 | $9.40 | $9.14 | $9.36 | $9.36 | 2,818 |
| 6/9/2026 | $9.25 | $9.60 | $9.25 | $9.56 | $9.56 | 11,300 |
Analyst Price Targets
Based on analyst covering PRN
Wall Street analysts forecast PRN stock price to rise 168.3% over the next 12 months.
Consensus
No RatingAvg. Target
C$25.03
+168.3% Upside
Current Price
C$9.33
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on PRN's historical volatility
30-Day Vol
42.9%
Annualized
90-Day Vol
82.3%
Annualized
Trend (90d)
+24.8%
Annualized drift
90d Mean
C$10.19
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$9.61 | C$8.29 โ C$11.14 |
| 60 trading days | C$9.90 | C$8.03 โ C$12.20 |
| 90 trading days | C$10.19 | C$7.89 โ C$13.17 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Profound Medical Corp
Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. The company's lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. It also provides Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. It operates in Canada, Germany, the United States, China, and Finland. Profound Medical Corp. is headquartered in Mississauga, Canada.
Financials
- Revenue (TTM)
- $18.81M
- EBITDA
- $-37.61M
- Profit Margin
- -206.76%
- ROE (TTM)
- -70.59%
- EPS (Diluted)
- -1.75
- Book Value
- 2.28
Classification
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Group
- Health Care Equipment & Services
Advertisement
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About PRN
Articles Featuring PRN.TO
Latest articles and analysis covering PRN.TO
Why Profound Medical Corp stock is gaining today
Profound Medical Corp's stock rose 0.73% in the last trading session, reflecting investor optimism following recent funding announcements aimed at bolstering its market presence.
Why Profound Medical Corp stock is rising today
Profound Medical Corp's stock is on the rise, closing at CA$9.64 with a 3.21% gain. This positive shift is attributed to recent financial strategies aimed at enhancing growth potential.
Why Profound Medical Corp stock is sliding today
Profound Medical Corp's stock fell 2.41% today, closing at CA$9.32. Investors are concerned about the implications of its recent capital raises and the overall financial health of the company.
Why Profound Medical Corp stock is sliding today
Profound Medical Corp's stock has experienced a significant drop today, raising questions about the sustainability of its recent financial successes amidst a challenging market environment.
Why Profound Medical Corp stock is rising today
Profound Medical Corp's stock is on the rise, closing up 2.07% today. This increase is fueled by positive investor sentiment following the company's impressive financial performance.
Why Profound Medical Corp stock is tanking today
Profound Medical Corp's stock took a hit today, closing down 1.82% at CA$9.17. Investors are left questioning the company's immediate future as it prepares for significant financial announcements.
